Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study

BACKGROUND: Transarterial chemoembolization (TACE) and sorafenib (SOR) are well-established treatments for hepatocellular carcinoma (HCC). This study evaluates the efficacy and safety of SOR combined with TACE in the treatment of patients with TACE-refractory, advanced-stage HCC. METHODS: This retro...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Onco Targets Ther
Päätekijät: Wu, Jianbing, Li, An, Yang, Jiajin, Lu, Yanjun, Li, Jie
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2017
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5457121/
https://ncbi.nlm.nih.gov/pubmed/28603426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S131022
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia